Answers are grounded in this paper and cite their sources.
Backgound: Cephalexin is one of the first generation cephalosporins that has antibactericidal activity against gram-positive microorganisms. The purpose of the present study is to evaluate the bioequivalence of two cephalexin formulations (Kepacin capsule 500mg vs Falexin capsule 500mg), according to the guideline of the Korea Food and Drug Administration (KFDA) Methods: Twenty three healthy Korean male volunteers participated in this study. Under two-way, crossover, Latin-square design (1-week wash-out period), a pharmacokinetic study and bioequivalence test was performed. After oral administration of cephalexin 500mg, blood samples were taken at predetermined time points and the concentrations of cephalexin were quantified using HPLC/UV method. WinNonlin V5.0 was utilized for calculation of the pharmacokinetic parameters including AUCt, Cmax. Results: There were no significant differences in demographic and pharmacokinetic characteristics between Kepacin TM and Falexin
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: